<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=896170837107954&amp;ev=PageView&amp;noscript=1">

Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc

Minimally Invasive Procedure Now Available to Hundreds of Thousands More Men with Enlarged Prostate, Providing Safe and Effective Symptom Relief.

Read More

Teleflex Announces Urology Times Article Highlighting the UroLift System as Providing a Superior Patient Experience for Treating Enlarged Prostate

Minimally Invasive Treatment Options for BPH Remain Critical Due to Shortcomings of Surgery and Medication

Read More

Teleflex Announces Publication of a Large Real-World Study Confirming Results from Controlled Clinical Studies of the UroLift® System

Results from Multi-Center Study Support the Application of Minimally Invasive Treatment for Broader BPH Population

Read More

Teleflex Announces Expanded Nationwide Coverage for the UroLift System for Patients with Enlarged Prostate

Coverage Decision by Anthem Increases Access to Minimally Invasive Treatment, Offering Patients Rapid, Durable Symptom Relief

Read More

Teleflex Announces Positive Results from Five Studies Underscoring the Effectiveness and Versatility of the UroLift® System Treatment for BPH

Real-World Data Presented at American Urological Association Meeting Highlight Consistency with Controlled Studies and Effectiveness in Diverse Patient Populations

Read More

Teleflex Announces Multiple Data Presentations from Studies of the UroLift® System Treatment for Enlarged Prostate at the American Urological Association 2019 Meeting

Data featuring real-world findings in a large, multi-center study, and effectiveness and sexual function preservation in diverse patient populations to be presented at the Annual Meeting of the American Urological Association
Read More

Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate

Findings Presented at European Association of Urology Show Consistent Positive Results for Minimally Invasive UroLift System Treatment  

Read More

NeoTract Announces 100,000 Patients Treated for Enlarged Prostate with UroLift® System

Minimally Invasive UroLift System Treatment Provides Rapid Symptom Relief and Improved Quality of Life, While Preserving Sexual Function*1,2

Read More

NeoTract Announces Expanded Coverage for UroLift System Treatment for Patients with Enlarged Prostate

Favorable Coverage Decisions Broaden Access to This Minimally Invasive Treatment That Provides Rapid Relief and Recovery from Symptoms

Read More

Data Suggest That Men Should Resolve to Address Their BPH Symptoms in 2019

NeoTract Study Finds That Men Over 40 Are Not Aware that Delaying Treatment of Benign Prostatic Hyperplasia (BPH) Can Cause Permanent Bladder Damage or of Treatment Options

Read More